POPULATION PHARMACOKINETIC (PK) MODELING AND SIMULATION OF VARIOUS DOSING INTERVALS AND DETERMINATION OF THE DOSE ADJUSTMENT FACTOR AFTER SC ADMINISTRATION OF IMMUNOGLOBULIN 20% (SCIG 20%) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD)

Dumas Todd; Wolfsegger Martin; Berry N. Seth; McCoy Barbara; Yel Leman

首页> 外文期刊>Journal of Clinical Immunology >POPULATION PHARMACOKINETIC (PK) MODELING AND SIMULATION OF VARIOUS DOSING INTERVALS AND DETERMINATION OF THE DOSE ADJUSTMENT FACTOR AFTER SC ADMINISTRATION OF IMMUNOGLOBULIN 20% (SCIG 20%) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD)

【24h】

POPULATION PHARMACOKINETIC (PK) MODELING AND SIMULATION OF VARIOUS DOSING INTERVALS AND DETERMINATION OF THE DOSE ADJUSTMENT FACTOR AFTER SC ADMINISTRATION OF IMMUNOGLOBULIN 20% (SCIG 20%) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD)

机译：各种给药间隔的人口药代动力学（PK）模拟和模拟初级免疫缺陷患者SC施用免疫球蛋白20％（SCIG 20％）施用剂量调整因子的测定

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Clinical Immunology》 |2017年第2期|共2页
作者
Dumas Todd; Wolfsegger Martin; Berry N. Seth; McCoy Barbara; Yel Leman;
展开▼
作者单位

Quintiles Overland Pk KS USA;

Shire Vienna Austria;

Quintiles Overland Pk KS USA;

Shire Cambridge MA USA;

Shire Cambridge MA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词

相似文献

外文文献

1. POPULATION PHARMACOKINETIC (PK) MODELING AND SIMULATION OF VARIOUS DOSING INTERVALS AND DETERMINATION OF THE DOSE ADJUSTMENT FACTOR AFTER SC ADMINISTRATION OF IMMUNOGLOBULIN 20% (SCIG 20%) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD) [J] . Dumas Todd, Wolfsegger Martin, Berry N. Seth, Journal of Clinical Immunology . 2017,第2期

机译：各种给药间隔的人口药代动力学（PK）模拟和模拟初级免疫缺陷患者SC施用免疫球蛋白20％（SCIG 20％）施用剂量调整因子的测定
2. VALIDATION OF A POPULATION PHARMACOKINETIC MODEL OF SUBCUTANEOUS IMMUNOGLOBULIN (IGPRO20) AFTER WEEKLY AND BIWEEKLY DOSING IN PRIMARY IMMUNODEFICIENCY PATIENTS. [J] . Zhang Y., Baheti G., Rojavin M., Clinical Pharmacology and Therapeutics . 2018,第Suppla1期

机译：原发性免疫缺陷患者每周和双周给药后皮下免疫球蛋白（IGPRO20）的人口药代动力学模型。
3. VALIDATION OF A POPULATION PHARMACOKINETIC MODEL OF SUBCUTANEOUS IMMUNOGLOBULIN (IGPRO20) AFTER WEEKLY AND BIWEEKLY DOSING IN PRIMARY IMMUNODEFICIENCY PATIENTS. [J] . Zhang Y., Baheti G., Rojavin M., Clinical Pharmacology and Therapeutics . 2018,第Suppla1期

机译：原发性免疫缺陷患者每周和双周给药后皮下免疫球蛋白（IGPRO20）的人口药代动力学模型。
4. Clinical pharmacokinetic simulation/modeling as a tool for therapeutic drug monitoring and dose adjustment in special patient populations. [D] . Mohamed, Osama H. 2004

机译：临床药代动力学模拟/建模，作为特殊患者人群中治疗药物监测和剂量调整的工具。
5. Calculating the Dose of Subcutaneous Immunoglobulin for Primary Immunodeficiency Disease in Patients Switched From Intravenous to Subcutaneous Immunoglobulin Without the Use of a Dose-Adjustment Coefficient [O] . Michael Fadeyi, Tin Tran 2013

机译：在不使用剂量调整系数的情况下计算从静脉内转为皮下免疫球蛋白的原发性免疫缺陷疾病的皮下免疫球蛋白的剂量
6. Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes [O] . Dinh H. Vu, Duy A. Nguyen, Isabelle K. Delattre, 2019

机译：用于连续输注万古霉素在批判性患者中的最佳载荷和维持剂量的测定：种群药代动力学建模和改进给药方案的模拟

POPULATION PHARMACOKINETIC (PK) MODELING AND SIMULATION OF VARIOUS DOSING INTERVALS AND DETERMINATION OF THE DOSE ADJUSTMENT FACTOR AFTER SC ADMINISTRATION OF IMMUNOGLOBULIN 20% (SCIG 20%) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD)

著录项

相似文献

相关主题

期刊订阅